Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

UNCY Unicycive Therapeutics Inc

0,44

0,0201 (4,79%)

01 Aug 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Unicycive Therapeutics (NASDAQ:UNCY)
Historical Stock Chart
Von Jul 2024 bis Aug 2024

Click Here for more Unicycive Therapeutics Charts.

Unicycive Therapeutics (NASDAQ:UNCY)
Historical Stock Chart
Von Aug 2023 bis Aug 2024

Click Here for more Unicycive Therapeutics Charts.

News Unicycive Therapeutics Inc

Unicycive Therapeutics Granted Patent on UNI-494 to Treat Acute Kidney Injury by the United States Patent and Trademark Office (USPTO)
Mittwoch 17 Juli 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Mittwoch 17 Juli 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Dienstag 16 Juli 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 15 Juli 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 15 Juli 2024 (2 Wochen vor) • Edgar (US Regulatory)

Unicycive Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 3rd Annual Kidney Virtual Conference
Donnerstag 11 Juli 2024 (3 Wochen vor) • GlobeNewswire Inc.

Unicycive Therapeutics Announces Initial Positive Patient Satisfaction Findings from Pivotal Clinical Trial of Oxylanthanum Carbonate (OLC)
Mittwoch 10 Juli 2024 (3 Wochen vor) • GlobeNewswire Inc.

Unicycive Therapeutics Joins Russell Microcap® Index
Montag 1 Juli 2024 (1 Monat vor) • GlobeNewswire Inc.

Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial
Dienstag 25 Juni 2024 (1 Monat vor) • GlobeNewswire Inc.

Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress
Dienstag 28 Mai 2024 (2 Monate vor) • GlobeNewswire Inc.

Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor Conference
Donnerstag 23 Mai 2024 (2 Monate vor) • GlobeNewswire Inc.

Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting
Mittwoch 15 Mai 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Unicycive Therapeutics Inc News-Artikel

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen